Showing results (221-230 of 359) with videos related to

Sort By:
Pageof 36
Cancer Letters|September 11, 2008
Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonistsJun Wei, Michele F Rega, Shinichi Kitada, et al.
Journal of Cellular Biochemistry. Supplement|January 29, 2003
Advances in molecular labeling, high throughput imaging and machine intelligence portend powerful functional cellular biochemistry toolsJeffrey H Price, Angela Goodacre, Klaus Hahn, et al.
The Journal of Biological Chemistry|July 13, 2005
LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3ShuangDing Wu, Ping Xie, Kate Welsh, et al.
Brain Pathology (Zurich, Switzerland)|December 6, 2003
BAG1 over-expression in brain protects against strokePawel Kermer, Murat H Digicaylioglu, Marcus Kaul, et al.
Journal of Cancer Research and Clinical Oncology|October 24, 2012
Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovaryDirk Bauerschlag, Karen Bräutigam, Roland Moll, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2006
Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting BidBarbara Becattini, Carsten Culmsee, Marilisa Leone, et al.
Cancer Chemotherapy and Pharmacology|March 16, 2007
Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetateLee Jia, Lori C Coward, Corenna D Kerstner-Wood, et al.
Structure (London, England : 1993)|May 15, 2002
Downstream regulator TANK binds to the CD40 recognition site on TRAF3Chenglong Li, Chao-Zhou Ni, Marnie L Havert, et al.
Pageof 36